# Valencia Nutrit (NSE: VALENCIA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/VALENCIA · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹132 Cr, it ranks 2508th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.

Its return on equity was 2.9% in FY25. Promoters held 64.18% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹132 Cr |
| ROE | 2.9% (FY25) |
| ROCE | 3.2% (FY25) |
| Debt to equity | 0.04 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹8 Cr | ₹1 Cr |
| FY24 | ₹1 Cr | −₹1 Cr |
| FY23 | ₹1 Cr | −₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 64.18%
- Non-institutions: 35.82%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Smruthi Organic](https://app.pivotnow.in/stock/SMRUTHIORG) | — | ₹135 Cr | — | — |
| [Lactose India](https://app.pivotnow.in/stock/LACTOSE) | — | ₹132 Cr | — | — |
| [Par Drugs And Chemicals](https://app.pivotnow.in/stock/PAR) | ₹105.25 | ₹130 Cr | 9.9 | — |
| [Aspira Pathlab](https://app.pivotnow.in/stock/ASPIRA) | — | ₹125 Cr | — | — |
| [Parnax Lab](https://app.pivotnow.in/stock/PARNAXLAB) | ₹108.95 | ₹125 Cr | 10.6 | — |
| [Krebs Biochemicals and Industries](https://app.pivotnow.in/stock/KREBSBIO) | ₹57.16 | ₹123 Cr | — | — |

## Questions and answers

### What is the market cap of Valencia Nutrit?

Valencia Nutrit's market capitalisation is ₹132 Cr (₹132 Cr) at the 19 Oct 2026 close, ranking 2508th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Valencia Nutrit?

Return on equity was 2.9% in FY25 and return on capital employed was 3.2% in FY25 (standalone figures).

### Is Valencia Nutrit a debt-free company?

Valencia Nutrit is close to debt-free: its debt-to-equity ratio was 0.04 in FY25.

### What is the shareholding pattern of Valencia Nutrit?

As of 30 Jun 2026: promoters 64.18%, non-institutions 35.82%.

### Who are Valencia Nutrit's competitors?

The listed Pharma & Healthcare companies closest to Valencia Nutrit by market cap are Smruthi Organic, Lactose India, Par Drugs And Chemicals, Aspira Pathlab, Parnax Lab and Krebs Biochemicals and Industries.

### Is Valencia Nutrit a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Valencia Nutrit's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VALENCIA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.